ArticleBioengineering (Basel, Switzerland)2025
IDCC-SAM: A Zero-Shot Approach for Cell Counting in Immunocytochemistry Dataset Using the Segment Anything Model.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Cell counting in immunocytochemistry is vital for biomedical research, supporting the diagnosis and treatment of diseases such as neurological disorders, autoimmune conditions, and cancer. However, traditional counting methods are manual, time-consuming, and error-prone, while deep learning solutions require costly labeled datasets, limiting scalability. We introduce the Immunocytochemistry Dataset Cell Counting with Segment Anything Model (IDCC-SAM), a novel application of the Segment Anything Model (SAM), designed to adapt the model for zero-shot-based cell counting in fluorescent microscopic immunocytochemistry datasets. IDCC-SAM leverages Meta AI's SAM, pre-trained on 11 million images, to eliminate the need for annotations, enhancing scalability and efficiency. Evaluated on three public datasets (IDCIA, ADC, and VGG), IDCC-SAM achieved the lowest Mean Absolute Error (26, 28, 52) on VGG and ADC and the highest Acceptable Absolute Error (28%, 26%, 33%) across all datasets, outperforming state-of-the-art supervised models like U-Net and Mask R-CNN, as well as zero-shot benchmarks like NP-SAM and SAM4Organoid. These results demonstrate IDCC-SAM's potential to improve cell-counting accuracy while reducing reliance on specialized models and manual annotations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.